The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.

The IL-1 cytokine family includes eleven members, among which Il-36α, β and γ, IL-36Ra and IL-38. The IL-36 cytokines are involved in the pathogenesis of psoriasis. IL-38 is also expressed in the skin and was previously proposed to act as an IL-36 antagonist. In this study, we thus examined expressi...

Full description

Bibliographic Details
Main Authors: Jennifer Palomo, Sabina Troccaz, Dominique Talabot-Ayer, Emiliana Rodriguez, Gaby Palmer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5858842?pdf=render
_version_ 1819263858362023936
author Jennifer Palomo
Sabina Troccaz
Dominique Talabot-Ayer
Emiliana Rodriguez
Gaby Palmer
author_facet Jennifer Palomo
Sabina Troccaz
Dominique Talabot-Ayer
Emiliana Rodriguez
Gaby Palmer
author_sort Jennifer Palomo
collection DOAJ
description The IL-1 cytokine family includes eleven members, among which Il-36α, β and γ, IL-36Ra and IL-38. The IL-36 cytokines are involved in the pathogenesis of psoriasis. IL-38 is also expressed in the skin and was previously proposed to act as an IL-36 antagonist. In this study, we thus examined expression and function of Il-38 in a mouse model of imiquimod (IMQ)-induced skin inflammation. Il-38 mRNA was detected in the epidermis and in primary mouse keratinocytes, but not in dermal fibroblasts. At the peak of IMQ-induced inflammation, skin Il-38 mRNA levels were reduced, whereas Il-36ra mRNA expression increased. The severity of IMQ-induced skin inflammation, as assessed by recording ear thickness and histological changes, was similar in Il-38 KO and WT littermate control mice, while, in contrast, Il-36ra-deficient mice displayed more severe skin pathology than their WT littermates. Il-38-deficiency had no impact on IMQ-induced expression of proinflammatory mediators in the skin in vivo, on the basal expression of various cytokines or chemokines by cultured primary keratinocytes and dermal fibroblasts in vitro, or on the response of these cells to Il-36β. Finally, after cessation of topical IMQ application, the resolution of skin inflammation was also not altered in Il-38 KO mice. In conclusion, Il-38-deficiency did not impact the development or resolution of IMQ-induced skin inflammation. Our observations further suggest that endogenous Il-38 does not exert Il-36 inhibitory activity in this model, or in cultured skin cells. A potential anti-inflammatory function of Il-38 in mouse skin thus still remains to be demonstrated.
first_indexed 2024-12-23T20:20:16Z
format Article
id doaj.art-11186fad290a477a88c7b9c9d3587601
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-23T20:20:16Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-11186fad290a477a88c7b9c9d35876012022-12-21T17:32:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01133e019466710.1371/journal.pone.0194667The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.Jennifer PalomoSabina TroccazDominique Talabot-AyerEmiliana RodriguezGaby PalmerThe IL-1 cytokine family includes eleven members, among which Il-36α, β and γ, IL-36Ra and IL-38. The IL-36 cytokines are involved in the pathogenesis of psoriasis. IL-38 is also expressed in the skin and was previously proposed to act as an IL-36 antagonist. In this study, we thus examined expression and function of Il-38 in a mouse model of imiquimod (IMQ)-induced skin inflammation. Il-38 mRNA was detected in the epidermis and in primary mouse keratinocytes, but not in dermal fibroblasts. At the peak of IMQ-induced inflammation, skin Il-38 mRNA levels were reduced, whereas Il-36ra mRNA expression increased. The severity of IMQ-induced skin inflammation, as assessed by recording ear thickness and histological changes, was similar in Il-38 KO and WT littermate control mice, while, in contrast, Il-36ra-deficient mice displayed more severe skin pathology than their WT littermates. Il-38-deficiency had no impact on IMQ-induced expression of proinflammatory mediators in the skin in vivo, on the basal expression of various cytokines or chemokines by cultured primary keratinocytes and dermal fibroblasts in vitro, or on the response of these cells to Il-36β. Finally, after cessation of topical IMQ application, the resolution of skin inflammation was also not altered in Il-38 KO mice. In conclusion, Il-38-deficiency did not impact the development or resolution of IMQ-induced skin inflammation. Our observations further suggest that endogenous Il-38 does not exert Il-36 inhibitory activity in this model, or in cultured skin cells. A potential anti-inflammatory function of Il-38 in mouse skin thus still remains to be demonstrated.http://europepmc.org/articles/PMC5858842?pdf=render
spellingShingle Jennifer Palomo
Sabina Troccaz
Dominique Talabot-Ayer
Emiliana Rodriguez
Gaby Palmer
The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.
PLoS ONE
title The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.
title_full The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.
title_fullStr The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.
title_full_unstemmed The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.
title_short The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.
title_sort severity of imiquimod induced mouse skin inflammation is independent of endogenous il 38 expression
url http://europepmc.org/articles/PMC5858842?pdf=render
work_keys_str_mv AT jenniferpalomo theseverityofimiquimodinducedmouseskininflammationisindependentofendogenousil38expression
AT sabinatroccaz theseverityofimiquimodinducedmouseskininflammationisindependentofendogenousil38expression
AT dominiquetalabotayer theseverityofimiquimodinducedmouseskininflammationisindependentofendogenousil38expression
AT emilianarodriguez theseverityofimiquimodinducedmouseskininflammationisindependentofendogenousil38expression
AT gabypalmer theseverityofimiquimodinducedmouseskininflammationisindependentofendogenousil38expression
AT jenniferpalomo severityofimiquimodinducedmouseskininflammationisindependentofendogenousil38expression
AT sabinatroccaz severityofimiquimodinducedmouseskininflammationisindependentofendogenousil38expression
AT dominiquetalabotayer severityofimiquimodinducedmouseskininflammationisindependentofendogenousil38expression
AT emilianarodriguez severityofimiquimodinducedmouseskininflammationisindependentofendogenousil38expression
AT gabypalmer severityofimiquimodinducedmouseskininflammationisindependentofendogenousil38expression